39420980|t|The Role of Inducible Nitric Oxide Synthase in Assessing the Functional Level of Coronary Artery Lesions in Chronic Coronary Syndrome.
39420980|a|Chronic coronary syndrome (CCS) is a long-term manifestation of coronary artery disease, marked by stable but recurring chest pain and myocardial ischemia due to the gradual buildup of atherosclerotic plaques in the coronary arteries. It is a metabolic disorder of coronary arteries characterized by oxidative stress, endothelial dysfunction, inflammation, and hyperlipidemia. The imbalance in oxidative-antioxidative status contributes to stable ischemic heart disease. Oxidative stress involves reactive oxygen and nitrogen species, leading to low-density lipoprotein (LDL) oxidation. Endothelial dysfunction, marked by reduced nitric oxide (NO) bioavailability, is an early onset of CCS, affecting vasodilation, cell proliferation, and inflammatory responses. Enzyme myeloperoxidase (MPO), traditionally considered protective, plays a dual role in initiating and progressing inflammatory diseases. MPO interacts with NO, modulating its catalytic activity. Elevated NO levels inhibit MPO through a reversible complex formation, preventing NO-induced inhibition by inducible nitric oxide synthase (iNOS). MPO also inactivates endothelial nitric oxide synthase (eNOS) and reacts with L-arginine, hindering NO synthesis. The interplay between MPO and NO significantly influences inflammation sites, impacting peroxidation rates and oxidation reactions. Peroxynitrite, a reactive species, contributes to nitration of tyrosine residues and lipid peroxidation. Mechanistic pathways suggest MPO enhances iNOS catalytic activity, influencing CCS development. iNOS, implicated in inflammation and atherosclerosis, is connected to NO regulation. This review analyzes the complex interplay of MPO, iNOS, and NO that affects plaque morphology, oxidative stress, and inflammation, contributing to atherosclerosis progression. Therefore, it is possible that the phenotypes of atherosclerotic plaques, focal and diffuse coronary artery disease, could be defined by the relationship between MPO and iNOS.
39420980	12	43	Inducible Nitric Oxide Synthase	Gene	4843
39420980	81	104	Coronary Artery Lesions	Disease	MESH:D003324
39420980	108	133	Chronic Coronary Syndrome	Disease	MESH:D054058
39420980	135	160	Chronic coronary syndrome	Disease	MESH:D054058
39420980	162	165	CCS	Disease	MESH:D054058
39420980	199	222	coronary artery disease	Disease	MESH:D003324
39420980	255	265	chest pain	Disease	MESH:D002637
39420980	270	289	myocardial ischemia	Disease	MESH:D017202
39420980	320	343	atherosclerotic plaques	Disease	MESH:D058226
39420980	378	396	metabolic disorder	Disease	MESH:D008659
39420980	453	476	endothelial dysfunction	Disease	MESH:D014652
39420980	478	490	inflammation	Disease	MESH:D007249
39420980	496	510	hyperlipidemia	Disease	MESH:D006949
39420980	582	604	ischemic heart disease	Disease	MESH:D017202
39420980	632	668	reactive oxygen and nitrogen species	Chemical	-
39420980	722	745	Endothelial dysfunction	Disease	MESH:D014652
39420980	765	777	nitric oxide	Chemical	MESH:D009569
39420980	779	781	NO	Chemical	MESH:D009569
39420980	821	824	CCS	Disease	MESH:D054058
39420980	874	886	inflammatory	Disease	MESH:D007249
39420980	905	920	myeloperoxidase	Gene	4353
39420980	922	925	MPO	Gene	4353
39420980	1013	1034	inflammatory diseases	Disease	MESH:D007249
39420980	1036	1039	MPO	Gene	4353
39420980	1055	1057	NO	Chemical	MESH:D009569
39420980	1103	1105	NO	Chemical	MESH:D009569
39420980	1121	1124	MPO	Gene	4353
39420980	1176	1178	NO	Chemical	MESH:D009569
39420980	1201	1232	inducible nitric oxide synthase	Gene	4843
39420980	1234	1238	iNOS	Gene	4843
39420980	1241	1244	MPO	Gene	4353
39420980	1262	1295	endothelial nitric oxide synthase	Gene	4846
39420980	1297	1301	eNOS	Gene	4846
39420980	1319	1329	L-arginine	Chemical	MESH:D001120
39420980	1341	1343	NO	Chemical	MESH:D009569
39420980	1377	1380	MPO	Gene	4353
39420980	1385	1387	NO	Chemical	MESH:D009569
39420980	1413	1425	inflammation	Disease	MESH:D007249
39420980	1487	1500	Peroxynitrite	Chemical	MESH:D030421
39420980	1550	1558	tyrosine	Chemical	MESH:D014443
39420980	1572	1577	lipid	Chemical	MESH:D008055
39420980	1621	1624	MPO	Gene	4353
39420980	1634	1638	iNOS	Gene	4843
39420980	1671	1674	CCS	Disease	MESH:D054058
39420980	1688	1692	iNOS	Gene	4843
39420980	1708	1720	inflammation	Disease	MESH:D007249
39420980	1725	1740	atherosclerosis	Disease	MESH:D050197
39420980	1758	1760	NO	Chemical	MESH:D009569
39420980	1819	1822	MPO	Gene	4353
39420980	1824	1828	iNOS	Gene	4843
39420980	1834	1836	NO	Chemical	MESH:D009569
39420980	1891	1903	inflammation	Disease	MESH:D007249
39420980	1921	1936	atherosclerosis	Disease	MESH:D050197
39420980	1999	2022	atherosclerotic plaques	Disease	MESH:D058226
39420980	2042	2065	coronary artery disease	Disease	MESH:D003324
39420980	2112	2115	MPO	Gene	4353
39420980	2120	2124	iNOS	Gene	4843
39420980	Negative_Correlation	MESH:D009569	MESH:D014652
39420980	Association	MESH:D009569	MESH:D007249
39420980	Association	MESH:D058226	4843
39420980	Association	MESH:D003324	4843
39420980	Association	MESH:D054058	4353
39420980	Association	MESH:D008055	MESH:D030421
39420980	Positive_Correlation	4353	4843
39420980	Association	MESH:D050197	4843
39420980	Association	MESH:D009569	4353
39420980	Association	MESH:D054058	4843
39420980	Association	MESH:D009569	MESH:D050197
39420980	Association	MESH:D001120	4353
39420980	Negative_Correlation	4353	4846
39420980	Negative_Correlation	MESH:D009569	MESH:D054058
39420980	Association	MESH:D007249	4843
39420980	Positive_Correlation	MESH:D014443	MESH:D030421
39420980	Association	MESH:D007249	4353
39420980	Association	MESH:D009569	4843

